The widespread outbreak of infectious diseases such as avian influenza is a major factor driving the demand for diagnostic infrastructure in the poultry industry. Awareness campaigns by public and private bodies about avian diseases among poultry farmers are also having a positive impact on the industry.
Request a sample of this report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-12773
Moreover, concerns about food security and investments by governments and international bodies towards the intensive farming sector will lead to poultry farming. This will also support the long-term demand for poultry diagnostics.
- ELISA tests are expected to continue to hold a large market share until 2030, due to their superior accuracy and cost efficiency.
- It is estimated that avian influenza diagnoses reflect the high market share on the back of the prevalence of accidents in developing countries.
- Newer diseases such as Mortality Syndrome are expected to generate lucrative opportunities in terms of product development and interest from the veterinary sector.
- Virology services are expected to be a major contributor to the market due to the high risk of viral infection for human consumers.
- South Asia and the Pacific, will reflect rapid growth, with poor hygiene standards in developing nations. North America will continue to hold a larger market share, due to its superior infrastructure.
An increasing number of government initiatives towards animal health including investments in related health information portals are likely to provide impetus to the poultry diagnostics market. Increasingly stringent health and safety laws in the poultry industry, especially in developing countries, will positively impact the market. , FMI Analyst Comments
Ask an Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-12773
Insights on the impact of the coronavirus
As the COVID-19 outbreak continues to wreak havoc on the global economy, the poultry diagnostics market is also expected to be negatively affected during the crisis period. While chickens and other poultry are not at risk from the virus, the pandemic is likely to harm consumption, logistics and sales of birds. This can be largely attributed to the strict regulations on the food service business.
These factors are expected to reduce the chicken stock in the poultry industry in the short term, which in turn will reduce the demand for diagnostic tools and infrastructure in the industry. The market is likely to recover strongly as 2021 approaches, as demand for poultry products increases. Strict food safety laws and concerns about other strains of coronavirus will aid market developments.
The market leaders in the poultry diagnostics industry include but are not limited to Agrobiotek Internacional, Bioneer Corporation and Affinitech Ltd. and Zoetis Inc. and Biochek, Thermo Fisher Scientific, and Bioingentech Biotechnologies Inc. and Qiagen NV and Bionote Inc. and Megacor Diagnostik GmbH and Idexx Laboratories
Market participants are increasingly focusing on product research with the goal of developing and launching improved test tools for faster and accurate results. Additionally, acquisitions and strategic industry collaborations are used to build a foundation in a moderately competitive landscape.
In April 2020, BioChek announced its acquisition of BIOTECON, cementing the company’s presence as a market leader in PCR-based veterinary diagnostic solutions including diseases of the poultry industry.
Furthermore, Boehringer Ingelheim and Fraunhofer IME have collaborated to develop diagnostic and medicinal animal health products for parasitic diseases.
Also, in August 2020, IDEXX Laboratories released the ProCyte One Hematology Analyzer for point-of-care diagnostics in the veterinary industry, including applications in the poultry sector.
More insights into the poultry diagnostics market
In a new market study, Future Market Insights provided a comprehensive analysis of the global poultry diagnostics market, covering historical demand data from 2015 to 2019 and projected data from 2020 to 2030. The report provides insights into the poultry diagnostics market in terms of test type (ELISA test, PCR test, and others ), type of disease (avian salmonellosis, avian influenza, Newcastle disease, avian mycoplasmosis, avian pasteurellosis, infectious bronchitis, infectious bursa disease, avian encephalomyelitis, avian re-virus, chicken anemia), and service ( bacteriology, virology, and parasitology) across six major areas.
- ELISA test
- PCR test
The type of disease
- avian salmonellosis
- Bird flu
- Newcastle disease
- Avian mycoplasmosis
- Avian Pasteurellosis
- infectious bronchitis
- Infectious bursa disease
- Avian encephalomyelitis
- bird reovirus
- chicken anemia
- North America (US and Canada)
- Latin America (Brazil, Mexico, Argentina and the rest of Latin America)
- Europe (Germany, UK, France, Spain, Italy, BENELUX, Russia, Poland and rest of Europe)
- Middle East and Africa (GCC, North Africa, South Africa, Turkey, and rest of the Middle East and Africa)
- East Asia (China, Japan, and South Korea)
- South Asia (India, Thailand, Malaysia, Indonesia, Australia, New Zealand and rest of South Asia)
Buy the full report @ https://www.futuremarketinsights.com/checkout/12773
Answer the main questions in the report
What are the future prospects of the poultry diagnostics market?
What trends are affecting the poultry diagnostics market?
What is the most commonly used test category for diagnosing poultry?
How is COVID-19 affecting the poultry diagnostics market?
Who are the major players in the global poultry diagnostics market?
future market insights
Unit number: AU-01-H Gold Tower (AU), Part number: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
The United Arab Emirates
For sales inquiries: [email protected]
For media inquiries: [email protected]